Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: The Baltimore Sun reported that Catherine Pugh continues to convalesce at home and is under doctors' supervision. She abruptly took leave April 1. "While her well-known tireless energy has been diminished by this illness, her doctors are confident she will recover her health and strength in due course," Pugh's personal attorney, Steven Silverman, told The Sun. "I know she is grateful for the good wishes of concern and support that she's received." Pugh was admitted to Johns Hopkins Hospital in late March, before she took leave and just as the scandal began to grow. The scandal involves her sales of her "Healthy Holly" children's books to the University of Maryland Medical System, where she sat on the board. Details also emerged that she had collected hundreds of thousands of dollars for her books from entities doing business with the city of Baltimore. Maryland Gov. Larry Hogan asked a state prosecutor to begin a criminal investigation. Many city and state lawmakers have called for her resignation. All but one member of the Baltimore City Council have called for Pugh to step down. U.S. Rep. Andy Harris told The Sun that Baltimore needs a new leader. "There are enough questions legitimate questions cast about this that I think the mayor probably can no longer be an effective leader of the city," the Republican said. But the people closest to Pugh say her health, not the scandal, is keeping her from public view. "She's recovering day by day," said James Bentley, her spokesman. "She's focused on getting healthy, and remains committed to Baltimore." The Sun reported that Pugh, 69, has not publicly faced serious medical issues previously. Neither she nor her advisers have offered details about the nature of her pneumonia. Dr. Paul Auwaerter, clinical director of the division of infectious diseases at the Johns Hopkins University School of Medicine, told the newspaper that recovery times can vary. After people seek treatment, and particularly if they've been hospitalized, they are on average "feeling better within 48 to 72 hours," though it "might take five to seven days" to bounce back completely, he said. But he said it can take longer if complicating factors are involved, such as stress. ___ Information from: The Baltimore Sun, http://www.baltimoresun.com

Output: Advisers: Baltimore's mayor still recovering from pneumonia.

Input: Consider Input: The alert urged Americans to seek medical help in the event they suffered any "unusual, unexplained physical symptoms or events, auditory or sensory phenomena, or other health concerns." The alert comes as a U.S. medical team is screening more Americans who work at the Guangzhou consulate. A previous case in Guangzhou, disclosed last month, prompted the tests. The incidents have raised fears the unexplained issues that started in Cuba in 2016 have expanded to other countries. China says it has uncovered no information that could point to a cause. The most recent evacuations followed medical testing that revealed they might have been affected. State Department spokeswoman Heather Nauert said "a number of individuals" had been brought to the U.S. but didn't say how many were affected or evacuated. Friday's alert called for people to be attentive of symptoms including "dizziness, headaches, tinnitus, fatigue, cognitive issues, visual problems, ear complaints and hearing loss, and difficulty sleeping." It urged them "not to attempt to locate the source of any unidentified auditory sensation. Instead, move to a different location." The U.S. government has deemed the Cuba incidents "specific attacks" on American workers but hasn't publicly identified a cause or culprit. Most of the incidents were accompanied by bizarre, unexplained sounds that initially led U.S. investigators to suspect a sonic attack. Asked about the latest incidents, Chinese Foreign Ministry spokeswoman Hua Chunying said Thursday that the U.S. had not formally raised the matter with Beijing. "If the U.S. makes formal contact with us, China will continue necessary investigations in an earnest and responsible manner and maintain close communication and cooperation with the U.S.," Hua said at a regularly scheduled news conference. China earlier said it had looked into the case announced last month but came up with no clues about the cause of the symptoms. A U.S. official, who wasn't authorized to discuss the situation publicly and requested anonymity, said the evacuated American government workers were being brought from China for testing to the University of Pennsylvania. That's where doctors have been treating and studying patients previously evacuated from the U.S. Embassy in Havana. The preliminary findings of the medical reports on the 24 personnel affected in Cuba showed they had sensory and memory problems similar to the brain dysfunction seen with concussions. The Penn team said the patients from Cuba experienced persistent disability though rehabilitation therapy customized for them seemed to help. Canada in April also ordered families of diplomatic staff in Cuba to return home after mysterious health symptoms were detected in 10 Canadians stationed on the island. Canada said the 10 continued to show unexplained brain symptoms and that "medical information raised concerns for a new type of a possible acquired brain injury." In testimony before the Senate Foreign Relations Committee last month about the first case in China, U.S. Secretary of State Mike Pompeo said China had "said all the right things and have demonstrated their willingness to help us identify the vector which led to this medical incident." The China incidents affect one of the most important of the seven U.S. diplomatic outposts in the country. The Guangzhou consulate opened months after the establishment of diplomatic relations between Beijing and Washington in 1979 and moved to its new purpose-built facility in 2013. It serves four southern provinces with a combined population of more than 204 million and processes more than 1 million visa applications of all types annually. It is also the only U.S. diplomatic installation in China authorized to process immigrant visas and handle adoptions. People working in The Canton Place complex, a few kilometers (miles) from the consulate, said Thursday they were just hearing about the incidents, reflecting a lack of coverage in China's entirely state-controlled media. Aled Williams, a British teacher at a kindergarten said Thursday that the reports sounded "sci-fi-ish." "Hard to get my head around how it works," he said. "Better watch myself." Linda Chen, who runs a coffee shop in the area, said she was mystified as to why only certain people seemed to have been affected in an area known for its comfort and safety. "For me I feel it's very strange. But I don't feel that there's something to be very afraid of because it's probably a very special case," Chen said. ___ Associated Press writer Josh Lederman in Washington, D.C. contributed to this report.

Output: US Embassy in China sends new alert for mystery health issue.

Input: Consider Input: The story clearly points out that brain scans and biomarker tests are not ready for clinical use. Since there are no recommended changes that directly affect readers today, and since it is not known which diagnostic tests may eventually prove useful, it is reasonable to put off discussions of cost. As noted above, the story points out that brain scans and biomarker tests for early signs of Alzheimer's disease are currently useful to researchers, not doctors in routine clinical practice. The story also reports that, "Current treatments do not alter the course of Alzheimer's, they just ease symptoms," thus limiting the benefit of early diagnosis. However, as we mentioned in the section on harms, the story would have been better if it offered more context with the comments of one expert who said that early diagnosis can help patients and families cope with the disease. Since the story reports that the diagnostic tests for Alzheimer's are not ready for clinical use and it points out that diagnosis is of limited value now because the available treatments are only able to ease some symptoms in some patients, not treat the underlying disease, we understand why discussion of potential harms is deferred. However, the story does include comments about perceived benefits of early diagnosis for patients and families. It would have been nice to see comments about why people might reasonably choose to defer diagnosis because of the psychological and social effects of being defined as an Alzheimer's patient when there may be no medical benefit to early diagnosis. This story is careful to point out the limitations of the brain scans, spinal fluid tests and other diagnostic tools being explored by researchers. It summarizes some of the key challenges that researchers need to address before trying to use scans or lab tests to diagnose patients in routine clinical practice. The story specifies the estimated size of the patient population: "About 5.4 million Americans and more than 26 million people worldwide have Alzheimer's, the most common form of dementia." It does not exaggerate the relevant population. This story summarizes the point of view of the panel of experts that developed these new guidelines for diagnosing Alzheimer's disease. However, it does not tell readers whether there are dissenting opinions. More importantly, the story fails to report relationships between some of the quoted experts and pharmaceutical or testing companies. For example, the disclosure statements with the journal articles announcing the guidelines state that "Marilyn Albert serves as a consultant to Genentech and Eli Lilly and receives grants to her institution from GE Healthcare" and "Guy McKhann serves on a Data Safety Monitoring Board for Merck." Readers should have been alerted to these industry ties. The story implicitly recognizes the option of foregoing testing by listing the limitations and uncertainties of not only experimental scans and lab tests, but also the limited utility of clinical diagnosis given the lack of effective treatments for Alzheimer's disease. The story alerts readers to not expect immediate changes in how doctors diagnose patients with signs of dementia: "Yet the guidelines do not advise doctors to change how they evaluate and treat patients now. Despite the hoopla about new brain scans and blood and spinal fluid tests that claim to show early signs of Alzheimer's, they are not ready for prime time and should remain just tools for research, the guidelines say." The story distinguishes between experimental diagnostic tools and the clinical features of dementia that doctors can use today when trying to determine whether a patient's symptoms indicate Alzheimer's or some other neurologic disease or injury. The story explains to readers key differences between the new guidelines and those released in 1984. It notes that the scans and lab tests that have been developed in recent years are useful to researchers trying to understand Alzheimer's disease, especially early in the disease process, and the effects of experimental treatments. The story does not appear to rely on a news release.
Output: New guidelines define pre-Alzheimer's disease